Eugia US LLC
Mark Fedele has a diverse work experience in the pharmaceutical industry. Mark worked as the President at AuroMedics Pharma LLC since July 2017, and prior to that, they served as the Sr. Vice President, Commercial Operations at the same company from June 2011 to July 2017. Before joining AuroMedics Pharma LLC, Mark worked as an Executive Consultant at SC Pharma from September 2010 to June 2011, where they provided advisory services on commercialization and corporate structuring. Mark also worked as the CEO at Parenta Pharmaceuticals from February 2007 to May 2010, overseeing various departments such as Sales, Marketing, Finance, Research & Development, Quality, Regulatory Affairs, and Commercial Operations. Prior to that, Mark held positions at Generamedix as the Vice President, Sales and National Accounts from October 2004 to March 2007, and at Baxter as the Vice President, National Accounts from March 2002 to October 2004. Their earlier work experience includes being a Regional Sales Manager at ConvaTec, A Bristol Myers Squibb Company from June 1994 to April 2000.
Mark Fedele attended Bloomsburg University of Pennsylvania from 1976 to 1980, earning a B.S. degree in Marketing.
This person is not in any offices
Eugia US LLC
Eugia is an independent specialty pharmaceutical company focused on delivering generic sterile injectables, oncology, hormones, and ophthalmic medicines. Our best-in-class, dedicated manufacturing and R&D capabilities are poised to meet today’s customer needs, and we are committed to providing our customers and partners with high-quality specialty medicines. Our name embodies who we aspire to be as a company – EU meaning “good” and hyGIA being the goddess of good health – together reflecting our focus on delivering products that are foundational to ensuring good health for millions of people around the world. For more information, visit EugiaUS.com